Ribavirin enhances interferon-stimulated gene transcription by activation of the interferon-stimulated response element

Hepatology

Volumn 53, Issue 4, 2011, Pages 1400-1401

  Pan, Qiuwei ^a   Tilanus, Hugo W ^a   Janssen, Harry L A ^a   van der Laan, Luc J W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON REGULATORY FACTOR 7; INTERFERON REGULATORY FACTOR 9; PEGINTERFERON ALPHA; RIBAVIRIN;

ANTIVIRAL ACTIVITY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEPATITIS C; HEPATITIS C VIRUS; LETTER; MONOTHERAPY; PRIORITY JOURNAL;

CELL LINE, TUMOR; DRUG SYNERGISM; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; INTERFERON REGULATORY FACTORS; POLYETHYLENE GLYCOLS; RIBAVIRIN; TRANSCRIPTIONAL ACTIVATION;

EID: 79953758209     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.24202     Document Type: Letter

References (10)

1. De Clercq E. Another ten stories in antiviral drug discovery (part C): "Old" and "new" antivirals, strategies, and perspectives. Med Res Rev 2009; 29: 611-645.
2. Pawlotsky JM, Dahari H, Neumann AU, Hezode C, Germanidis G, Lonjon I, et al. Antiviral action of ribavirin in chronic hepatitis C. Gastroenterology 2004; 126: 703-714.
3. Sidwell RW, Huffman JH, Khare GP, Allen LB, Witkowski JT, Robins RK. Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1, 2, 4-triazole-3-carboxamide. Science 1972; 177: 705-706.
4. Thomas E, Feld JJ, Li Q, Hu Z, Fried MW, Liang TJ. Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models. HEPATOLOGY 2011;53:32-41.
5. Feld JJ, Lutchman GA, Heller T, Hara K, Pfeiffer JK, Leff RD, et al. Ribavirin improves early responses to peginterferon through improved interferon signaling. Gastroenterology 2010; 139: 154-162.
6. Henry SD, Metselaar HJ, Lonsdale RC, Kok A, Haagmans BL, Tilanus HW, et al. Mycophenolic acid inhibits hepatitis C virus replication and acts in synergy with cyclosporin A and interferon-alpha. Gastroenterology 2006; 131: 1452-1462.
7. Darnell JE Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994; 264: 1415-1421.
8. Pedersen C, Alsio A, Lagging M, Langeland N, Farkkila M, Rauning Buhl M, et al. Ribavirin plasma concentration is a predictor of sustained virological response in patients treated for chronic hepatitis C virus genotype 2/3 infection. J Viral Hepat 2010; doi:10.1111/j. 1365-2893.2010.01303.x.
9. Buttmann M, Berberich-Siebelt F, Serfling E, Rieckmann P. Interferon-beta is a potent inducer of interferon regulatory factor-1/2-dependent IP-10/CXCL10 expression in primary human endothelial cells. J Vasc Res 2007; 44: 51-60.
10. Liu WL, Su WC, Cheng CW, Hwang LH, Wang CC, Chen HL, et al. Ribavirin up-regulates the activity of double-stranded RNA-activated protein kinase and enhances the action of interferon-alpha against hepatitis C virus. J Infect Dis 2007; 196: 425-434.